In contrast, deletion of Itgb8 in DCs using a Cd11c-Cre promoter had no effect on tumor growth, confirming the important role of T cell–specific Itgb8 expression in driving tumor growth via TGFβ activation (Dodagatta-Marri et al. 2021). Here, ITGAX is linked to neoplasm.